跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
诺和力 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Liraglutide Injection
Approved
生物制品
Liraglutide Injection
Novo Nordisk A/S
🇨🇳 National Medical Products Administration
Approval Date
Jun 11, 2020
Approval ID
7LeagVdlUdH
Company
Novo Nordisk A/S
Type
生物制品
Approval Details
Approval Id
7LeagVdlUdH
Approval Number
国药准字J20160037
Generic Name
利拉鲁肽注射液
Generic Name En
Liraglutide Injection
Trade Name
诺和力
Brand Name
诺和力
Drug Type
生物制品
Dosage Form
注射剂
Strength
3ml:18mg(预填充注射笔)
Reg Date
2020-06-11
Company Name
Novo Nordisk A/S
Company Address
Novo Alle, DK-2880 Bagsvaerd
Production Company Name
Novo Nordisk A/S
Production Company Address
Novo Alle, DK-2880 Bagsvaerd
Company Detail Path
/organization/novo-nordisk-a-s
Production Company Detail Path
/organization/novo-nordisk-a-s
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Jun 11, 2020
Approval ID
7LeagVdlUdH
Type
生物制品
Back to NMPA Approvals